SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-292510
Filing Date
2012-07-03
Accepted
2012-07-02 19:27:19
Documents
3
Period of Report
2012-06-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d376067d8k.htm 8-K 31444
2 AGREEMENT AND PLAN OF MERGER d376067dex21.htm EX-2.1 471867
3 ASSUMPTION AGREEMENT d376067dex101.htm EX-10.1 23936
  Complete submission text file 0001193125-12-292510.txt   528383
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19700 | Film No.: 12941716
SIC: 2834 Pharmaceutical Preparations